Evidence map›Paper›PMID 23724166›Full record

ArticleAmerican journal of translational research2013

SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses.

Ping Yang, Yushan Zhang, Junfa Xu, Shu Zhang, Qilin Yu, Junfeng Pang, Xiaoquan Rao, Michal Kuczma, Mario B Marrero, David Fulton and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Assessing the role of IL-35 in colorectal cancer progression and prognosis.International journal of clinical and experimental pathology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Ping YangThe Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology 1095 Jiefang Ave, Wuhan 430030, China.
Yushan Zhang
Junfa Xu
Shu Zhang
Qilin Yu
Junfeng Pang
Xiaoquan Rao
Michal Kuczma
Mario B Marrero
David Fulton
Piotr Kraj
Yunchao Su
Cong-Yi Wang
Augusta University Health · USHuazhong University of Science and Technology · CNInstitute of Pharmacology · CZGuangdong Medical College · CN

Funding

eNOS-actin Interaction and Oxygen in Lung EndotheliumR01HL088261 · NHLBI · UNIVERSITY OF FLORIDA · PI SU, YUNCHAO · 2008 to 2012
$1.8M
NHLBI NIH HHS R01 HL088261
6 · The paper itself

Abstract

As a versatile regulatory mechanism, sumoylation has been found to be essential for ordered diverse cellular processes. However, the exact impact of sumoylation on endothelial function largely remained elusive. Here we investigated the role of small ubiquitin-like modifier 1 (SUMO1) mediated sumoylation in the regulation of endothelial function by examining its effect on angiogenesis and homeostatic responses. Adenoviral-mediated SUMO1 expression in porcine aortic endothelial cells (PAECs) dose-dependently promoted proliferation, migration and tube formation. In line with these results in PAECs, Matrigel plug assays in SUMO1 transgenic mice demonstrated a significant higher capacity for vascular neogenesis as compared with that of control littermates. Moreover, SUMO1 expression protected PAECs from serum starvation or H2O2-induced apoptosis. Mechanistic studies demonstrated that SUMO1 sumoylation modulates ERK1/2 activation and MMP13 expression as well as Jak2/STAT5 signaling to promote angiogenesis. SUMO1 sumoylation also suppressed NFκB and c-JUN transcriptional activity to provide protection for PAECs against oxidative stress-induced apoptosis. Given that sumoylation is a reversible process, dynamic regulation of the sumoylation function could be a novel strategy to modulate endothelial function in disease states.

Indexed as

angiogenesisendothelial cellsSUMO1Sumoylation

Identifiers

PMID23724166
PMCPMC3665916
OpenAlexW1816308053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.